ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2018
Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017.
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
73 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Pooled it
- Point prevalence surveys of health-care-associated infections: a systematic review.Pathogens and global health · 2019Pooled it
- Effect of a multifaceted antibiotic stewardship intervention to improve antibiotic prescribing for suspected urinary tract infections in frail older adults (ImpresU): pragmatic cluster randomised controlled trial in four European countries.BMJ (Clinical research ed.) · 2023Trial
- Trial
- Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents: cluster randomised controlled trial.BMJ (Clinical research ed.) · 2021Trial
- Infection prevention and control procedures in nursing homes in the piedmont region of Italy: results from two regional surveys (2021-2024).Antimicrobial resistance and infection control · 2026Article
- Global Surveillance of Healthcare-Associated Infections in Long-Term Care Facilities: A Narrative Review.Microorganisms · 2026Review
- Effect of individual feedback on hand hygiene compliance in nursing homes.Infection prevention in practice · 2026Article
- Antimicrobial stewardship in Ireland (2010-2021): a scoping review.BMC health services research · 2026Article
- Antimicrobial use and stewardship activities in Swiss long-term care facilities: data from a national point-prevalence survey.Antimicrobial resistance and infection control · 2026Article
- Healthcare-associated infections in Italian long-term care facilities: a machine learning analysis of a 12-month cohort.Infection control and hospital epidemiology · 2026Article
- Factors influencing urinary tract infection prevention and antibiotic stewardship in European nursing homes: an interview study with staff.European geriatric medicine · 2025Article
- Infections and antibiotic treatment in long-term care facilities: results from 1-year cross sectional study in three Polish settings.Antimicrobial resistance and infection control · 2025Article
- Trends in antibiotic use in long-term care hospitals during the COVID-19 pandemic: a nationwide cohort study during 2020 and 2023.BMC infectious diseases · 2025Article
- First nationwide point-prevalence survey on healthcare-associated infections and antibiotic use in long-term care facilities, Switzerland, September 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
- Appropriateness of antibiotic use in nursing homes for suspected urinary tract infections: comparison across five European countries.European geriatric medicine · 2025Article
- The impact of a multifaceted intervention on antibiotic use for common infections in nursing homes in Spain. A before and after study.European geriatric medicine · 2025Article
- Surveillance of Healthcare-Associated Infections in Long-Term Care Facilities in Graz, Austria, from 2018 to 2022.Antibiotics (Basel, Switzerland) · 2025Article
- A shared approach to managing urinary tract infections in nursing homes improved perceived care quality, workload, and collaboration - a qualitative study.Scandinavian journal of primary health care · 2025Article
- Antimicrobial stewardship in the community setting: a qualitative exploratory study.Antimicrobial resistance and infection control · 2025Article
13 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobials are commonly prescribed and contribute to the development of antimicrobial resistance in long-term care facilities (LTCFs). In 2010, the European Centre for Disease Prevention and Control initiated point prevalence surveys (PPS) of healthcare-associated infections and antimicrobial use in European LTCFs, performed by external contractors as the Healthcare-Associated infections in Long-Term care facilities (HALT) projects. Here, we investigated prevalence and characteristics of antimicrobial use and antimicrobial stewardship indicators in European LTCFs in 2016-17. Twenty-four European Union/European Economic Area (EU/EEA) countries, the former Yugoslav Republic of Macedonia and Serbia participated in the third PPS in European LTCFs. Overall, 4.9% (95% confidence interval: 4.8-5.1) of LTCF residents in the EU/EEA participating countries received at least one antimicrobial. The most commonly reported Anatomical Therapeutic Chemical (ATC) groups were beta-lactam antibacterials/penicillins (J01C), other antibacterials (J01X) (e.g. glycopeptide antibacterials, polymyxins), quinolones (J01M), sulfonamides and trimethoprim (J01E), and other beta-lactams (J01D). Urinary tract infections and respiratory tract infections were the main indications for antimicrobial prescription. This PPS provides updated and detailed information on antimicrobial use in LTCFs across the EU/EEA that can be used to identify targets for future interventions, follow-up of these interventions and promote prudent use of antimicrobials in European LTCFs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.